Left ventricular hypertrophy (LVH) is the result of interaction between a c
hronic hemodynamic over load and non-hemodynamic factors. There ale several
lilies of evidence presented in this work suggesting that nitric oxide (NO
) may participate in the hypertrophic growth of the myocardium, First, endo
thelial NO production was shown to be decreased in several types of hemodyn
amically overloaded circulation both in animals and humans. Second. compoun
ds stimulating NO production were able to diminish the extent or modify the
nature of LVH in sonic models of myocardial hypertrophic growth. Third, ar
terial hypertension can be induced by inhibition of nitric oxide synthase a
ctivity, This NO-deficient hypertension is associated with the development
of concentric LVH, myocardial fibrosis and protein remodeling of the left v
entricle. The mechanism of LVH development in NO-deficient hypertension is
complex and involves decreased NO production and increased activation of th
e renin-angiotensin-aldosterone system. Cardiovascular protection I,ia ACE
inhibition in NO-deficient hypertension may be induced by mechanisms not in
volving all improvement of NO production. Tn conclusion, the hypertrophic g
rowth of the LV appears to be the result of interaction of vasoconstrictive
and growth stimulating effects of angiotensin II on the one hand and of va
sodilating and antiproliferative effects of nitric oxide on the other.